Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception

Background: Little is known about the cumulative effect of HIV antiretroviral therapy (ART) and hormonal contraception (HC) on metabolism and inflammation in HIV-positive women. Methods: We conducted a cross-sectional assessment of markers for carbohydrate, lipid, bone metabolism, inflammation and c...

Full description

Bibliographic Details
Main Authors: Nadia Kancheva Landolt, Torsak Bunupuradah, Jullapong Achalapong, Pope Kosalaraksa, Witaya Petdachai, Chaiwat Ngampiyaskul, Sasiwimol Ubolyam, Narukjaporn Thammajaruk, Stephen Kerr, Jintanat Ananworanich
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020302971
_version_ 1819093570622062592
author Nadia Kancheva Landolt
Torsak Bunupuradah
Jullapong Achalapong
Pope Kosalaraksa
Witaya Petdachai
Chaiwat Ngampiyaskul
Sasiwimol Ubolyam
Narukjaporn Thammajaruk
Stephen Kerr
Jintanat Ananworanich
author_facet Nadia Kancheva Landolt
Torsak Bunupuradah
Jullapong Achalapong
Pope Kosalaraksa
Witaya Petdachai
Chaiwat Ngampiyaskul
Sasiwimol Ubolyam
Narukjaporn Thammajaruk
Stephen Kerr
Jintanat Ananworanich
author_sort Nadia Kancheva Landolt
collection DOAJ
description Background: Little is known about the cumulative effect of HIV antiretroviral therapy (ART) and hormonal contraception (HC) on metabolism and inflammation in HIV-positive women. Methods: We conducted a cross-sectional assessment of markers for carbohydrate, lipid, bone metabolism, inflammation and coagulation in HIV-positive adolescents on ART and HC (n=37) versus on ART only (n=51) in Thailand. The Wilcoxon rank-sum test was used to assess differences between groups. Results: The median age was 19.5 years. Most adolescents (95%) were perinatally infected. All were on ART for a median of 9 years. HC used was progestin only (n=21); combined oral contraceptive (COC) tablets (n=6) for the whole study period or alternating between progestin only and COC (n=10). Prevalence of any metabolic abnormalities was 99%. Four biomarkers were significantly higher with HC vs no HC: insulin (10.3 vs 6.2μU/mL, P=0.002), insulin resistance (1.89 vs 1.19 mass units, P=0.005), 25-OH vitamin D (33.2 vs 20.2ng/mL, P<0.0001) and C-terminal telopeptide (690 vs 530ng/L, P=0.011). Triglycerides and D-dimer were significantly lower with HC (103 vs 139mg/dL, P=0.014 and 140 vs 155ng/mL, P=0.003, respectively). There was no relationship between the type of HC or ART and the above differences. Conclusion: Perinatally infected HIV-positive adolescents on ART in this pilot study had a high prevalence of metabolic abnormalities. Bone turnover markers and insulin resistance were significantly higher with HC. Research on the cumulative effect of HIV, ART and HC on metabolism and inflammation in adolescents with HIV is important in order to devise strategies for preventing and mitigating long-term comorbidities.
first_indexed 2024-12-21T23:13:37Z
format Article
id doaj.art-03805cd0088b450b97eed4be72065eb5
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-12-21T23:13:37Z
publishDate 2017-01-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-03805cd0088b450b97eed4be72065eb52022-12-21T18:46:58ZengElsevierJournal of Virus Eradication2055-66402017-01-01315660Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraceptionNadia Kancheva Landolt0Torsak Bunupuradah1Jullapong Achalapong2Pope Kosalaraksa3Witaya Petdachai4Chaiwat Ngampiyaskul5Sasiwimol Ubolyam6Narukjaporn Thammajaruk7Stephen Kerr8Jintanat Ananworanich9HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand; Corresponding author: Nadia Kancheva Landolt, HIV-NAT, Thai Red Cross AIDS Research Centre, 104 Rajdumri Road, Pathumwan, Bangkok, 10330, ThailandHIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, ThailandChiang Rai Prachanukroh Hospital, Chiang Rai, ThailandFaculty of Medicine, Khon Kaen University, Khon Kaen, ThailandPhra Chomklao Hospital Hospital, Phetchaburi, ThailandPhrapokklao Hospital, Chanthaburi, ThailandHIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, ThailandHIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, ThailandHIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand; Department of Global Health, University of Amsterdam, Amsterdam Institute for Global Health and Development, the NetherlandsHIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand; SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USABackground: Little is known about the cumulative effect of HIV antiretroviral therapy (ART) and hormonal contraception (HC) on metabolism and inflammation in HIV-positive women. Methods: We conducted a cross-sectional assessment of markers for carbohydrate, lipid, bone metabolism, inflammation and coagulation in HIV-positive adolescents on ART and HC (n=37) versus on ART only (n=51) in Thailand. The Wilcoxon rank-sum test was used to assess differences between groups. Results: The median age was 19.5 years. Most adolescents (95%) were perinatally infected. All were on ART for a median of 9 years. HC used was progestin only (n=21); combined oral contraceptive (COC) tablets (n=6) for the whole study period or alternating between progestin only and COC (n=10). Prevalence of any metabolic abnormalities was 99%. Four biomarkers were significantly higher with HC vs no HC: insulin (10.3 vs 6.2μU/mL, P=0.002), insulin resistance (1.89 vs 1.19 mass units, P=0.005), 25-OH vitamin D (33.2 vs 20.2ng/mL, P<0.0001) and C-terminal telopeptide (690 vs 530ng/L, P=0.011). Triglycerides and D-dimer were significantly lower with HC (103 vs 139mg/dL, P=0.014 and 140 vs 155ng/mL, P=0.003, respectively). There was no relationship between the type of HC or ART and the above differences. Conclusion: Perinatally infected HIV-positive adolescents on ART in this pilot study had a high prevalence of metabolic abnormalities. Bone turnover markers and insulin resistance were significantly higher with HC. Research on the cumulative effect of HIV, ART and HC on metabolism and inflammation in adolescents with HIV is important in order to devise strategies for preventing and mitigating long-term comorbidities.http://www.sciencedirect.com/science/article/pii/S2055664020302971
spellingShingle Nadia Kancheva Landolt
Torsak Bunupuradah
Jullapong Achalapong
Pope Kosalaraksa
Witaya Petdachai
Chaiwat Ngampiyaskul
Sasiwimol Ubolyam
Narukjaporn Thammajaruk
Stephen Kerr
Jintanat Ananworanich
Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
Journal of Virus Eradication
title Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
title_full Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
title_fullStr Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
title_full_unstemmed Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
title_short Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
title_sort carbohydrate lipid bone and inflammatory markers in hiv positive adolescents on antiretroviral therapy and hormonal contraception
url http://www.sciencedirect.com/science/article/pii/S2055664020302971
work_keys_str_mv AT nadiakanchevalandolt carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT torsakbunupuradah carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT jullapongachalapong carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT popekosalaraksa carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT witayapetdachai carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT chaiwatngampiyaskul carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT sasiwimolubolyam carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT narukjapornthammajaruk carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT stephenkerr carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception
AT jintanatananworanich carbohydratelipidboneandinflammatorymarkersinhivpositiveadolescentsonantiretroviraltherapyandhormonalcontraception